Search the Newsreel

Zentalis adds USD 80.5m as azenosertib nears pivotal test

Zentalis Pharmaceuticals has raised approximately USD 80.5 million through an equity offering to fund the late-stage development and pre-commercial activities for its oral WEE1 inhibitor, azenosertib. The drug is being evaluated for Cyclin E1-positive platinum-resistant ovarian cancer, with Phase II data expected by year-end …

Sri Havisha Q1 Results: Board approves unaudited financials

Calian Group Q3 Earnings Call Highlights

Key Points Interested in Calian Group Ltd.? Here are five stocks we like better. Record Q3 performance: Revenue rose 20% year over year to CAD 230 million, while adjusted EBITDA increased 35% to CAD 26 million. Organic growth reached 16%, and the adjusted EBITDA …

Lodging Lowdown: Radisson Hotel Group launches B2B extended stay program, Extended Stay America leader to retire

This story was originally published on Hotel Dive. To receive daily news and insights, subscribe to our free daily Hotel Dive newsletter. The Lodging Lowdown is a series from Hotel Dive highlighting major headlines that hospitality professionals may have missed from the week. This …

Wedge Capital Management L L P NC Buys 33,852 Shares of California Water Service Group $CWT

Dalipal Sets Board Meeting to Review Interim Results and Dividend

Shenzhen Hepalink Sets Board Meeting to Review Interim Results and Dividend

Duality Biotherapeutics Sets Board Meeting to Approve 2026 Interim Results

ALICON: Record sales, robust order book, and margin expansion targeted amid strong industry growth

Palisade Bio, Inc. (NASDAQ:PALI) Given Consensus Recommendation of "Buy" by Brokerages

Palisade Bio, Inc. (NASDAQ:PALI) has received a consensus "Buy" recommendation from brokerages, with an average one-year target price of $9.00. The article details recent analyst ratings, including several "buy" and "strong-buy" recommendations, alongside some changes to "hold" and "sell" ratings. It also highlights recent …

Ryman Hospitality Properties (RHP) Buys Grande Lakes Orlando, Is The Stock Fairly Valued?

Ryman Hospitality Properties (RHP) has acquired the Grande Lakes Orlando Resort for US$1.38 billion, accompanied by new equity and debt financing. Despite a recent share price rally and analyst targets suggesting fair valuation, Simply Wall St's analysis indicates the stock is about 7% undervalued …

Alicon Castallo Q1 Results FY27: Revenue Rs 578 crore, PAT Rs 11 Crore

Assenagon Asset Management S.A. Makes New Investment in California Water Service Group $CWT

Assenagon Asset Management S.A. has initiated a new investment in California Water Service Group (NYSE:CWT) during the second quarter, acquiring 42,371 shares valued at approximately $2.06 million. This investment contributes to institutional investors and hedge funds collectively owning 82.78% of the company. The utilities …

What's Going On With Inovalis Real Estate Investment Trust Stock Friday?

ALICON: Record sales, strong order book, and capacity expansion drive growth amid margin pressures

Denali Therapeutics (DNLI) Q2 2026 Earnings Call Transcript

Denali Therapeutics reported Q2 2026 earnings, highlighting its transition to a commercial-stage company following the successful launch of AVLAYAH, a new therapy for Hunter syndrome. The company achieved $3.6 million in net product revenue in its first full commercial quarter and provided Q3 guidance …

Earnings call transcript: Alicon Castalloy posts record Q1 2026 sales

Patanjali Foods Q1 Revenue Stands At ₹11,300 Crore, Standalone Net Profit At ₹336 Crore

Assicurazioni Generali Aktie | IT0000062072 | ETR:ASG | News & Aktienkurs | FRA:ASG

Tian An Australia Swings to Half-Year Loss as Property Sales and NTA Decline

Bubs Australia (ASX:BUB) Expands US Infant Nutrition Growth After EBITDA Turnaround

Biome Australia (ASX:BIO) Expands Probiotic Brand Growth With Record Sales

Tian An Australia Posts $3.9 Million Statutory Loss for Half-Year Ended 30 June 2026

Patanjali Foods Q1 Results Today: Time, Earnings Call, Dividend News, What To Watch, Share Price

Zentalis Pharmaceuticals slides after pricing 23M share public offering at $3.50/share

Zentalis Pharmaceuticals (ZNTL [https://seekingalpha.com/symbol/ZNTL]) announced the pricing of an underwritten public offering [https://seekingalpha.com/pr/20619418-zentalis-pharmaceuticals-announces-pricing-of-underwritten-public-offering] of 23M shares of its common stock at a public offering price of $3.50 per share. Gross proceeds from the offering are expected to be approximately $80.5M before deducting underwriting discounts, …

Zentalis Pharma Prices $80.5 Mln Offering Of Shares At $3.50 Per Share; Stock Down

(RTTNews) - Zentalis Pharmaceuticals, Inc. (ZNTL), a clinical-stage oncology company, priced a public offering of 23 million shares at $3.50 per share. The total gross proceeds from the offering are expected to be $80.5 million, and the company plans to use the net proceeds …

DMCC Speciality Chemicals posts sharp Q1 growth but warns profits may normalise

Country Club Hospitality & Holidays consolidated net profit rises 61.54% in the June 2026 quarter

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on Behalf of Investors

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA. This news led to a significant drop in Alignment Healthcare's stock …

Galilee Energy Raises A$3.5m to Fund Zydeco-1 Sidetrack and U.S. Gulf Coast Pivot

Ariadne Australia Discloses Substantial Holder Interest Change for Lorona Pty Ltd

Papyrus Australia Secures $500,000 in Unsecured Loan Facilities from Four Investors

Alicon Castalloy consolidated net profit rises 22.99% in the June 2026 quarter

Delta Galil Industries (TASE:DELG) Reaffirms Guidance As Strong Q2 Puts Valuation Back In Focus

Alithya Group Inc. 2027 Q1 - Results - Earnings Call Presentation (TSX:ALYA:CA) 2026-08-13

Key Points Interested in Alithya Group Inc.? Here are five stocks we like better. First-quarter results weakened significantly: Revenue fell 15.4% year over year to CAD 105.1 million, while adjusted EBITDA declined to CAD 5.4 million and the company posted a CAD 2.4 million …

Zentalis Pharmaceuticals prices $80.5M stock offering at $3.50

Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL) has announced the pricing of an underwritten public offering of 23 million shares of common stock at $3.50 per share, aiming to raise approximately $80.5 million in gross proceeds. The offering is expected to close on August 17, 2026, with …